Company snapshot
Market Cap
$90B
Large-cap2016 — today
10-Year Price
+445%
2016 — today
52-Week Range
$361.32$545.13
Current $402.02· 22%
Featured in rankings
S&P500Most Undervalued Healthcare StocksBest Healthcare Dividend StocksBest Healthcare GARP StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth Stocks
Rankings recomputed after each US market close — see where HCA stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ELVElevance Health Inc. | 17.9 | 1.7% |
| REGNRegeneron Pharmaceuticals, Inc. | 20.0 | 0.5% |
| GSKGSK plc | 15.1 | 3.7% |
| SNYSanofi | 75.7 | 5.6% |
| MCKMcKesson Corporation | 23.8 | 0.4% |
| SYKStryker Corporation | 28.6 | 1.3% |
| CICigna Corporation | 11.4 | 2.2% |
| MDTMedtronic plc | 22.8 | 3.1% |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
13.5
Around average
Around the 10-year average
Sector median 25.2below sector
P/B ratio
-28.5
N/A
Not meaningful — company is unprofitable
Sector median 2.6below sector
EV / EBITDA
8.7
Above average
Pricier than usual over the last 10 years
Sector median 15.6below sector
Dividend Yield
0.8%
Below average
Below the 10-year average
Sector median 1.7%below sector
PEG ratio
0.9
Above average
Pricier than usual over the last 10 years
Sector median 1.5below sector
FCF Yield
6.7%
Around average
Around the 10-year average
Sector median -9.4%above sector